Innovent Biologics (suzhou) Co. Ltd.

This study tests a new drug called IBI362 in 98 Chinese adults with moderate to severe obesity (BMI ≥ 32.5). Participants receive weekly injections of IBI362, tirzepatide, or a placebo for several weeks. The main goals are to check safety, side effects, and how the drug behaves i…

This study tests whether a new weekly injection called IBI362 works better than the existing drug semaglutide for weight loss and reducing liver fat in overweight or obese Chinese adults with metabolic dysfunction-associated fatty liver disease (MAFLD). About 479 participants wil…

This early-phase study tests a new drug called IBI363 in about 40 people with advanced solid tumors or lymphomas that haven't responded to other treatments. The main goal is to find the safest dose and check for side effects. Researchers will also measure how the drug moves throu…

This study tests whether giving two immunotherapy drugs (IBI310 and sintilimab) before surgery can eliminate or shrink tumors in people with a specific genetic type of colon cancer (MSI-H/dMMR). About 453 adults with stage IIB or III colon cancer that can be surgically removed wi…

This phase 3 study tests a new drug called IBI343 against standard treatments for people with advanced stomach or gastroesophageal junction cancer that has not responded to prior therapies. The trial includes 464 participants whose tumors have a specific marker (CLDN18.2) and lac…

This early-stage trial compares a new drug called IBI3027 to the approved medication Dupixent. It involves 180 healthy Chinese men who receive a single injection of either drug. The goal is to see if IBI3027 is absorbed and cleared from the body similarly to Dupixent, and to chec…

This early-stage trial is testing the safety and how the body handles a single dose of IBI3033 in 32 healthy Chinese adults. Participants receive either the drug or a placebo and are monitored for side effects and drug levels over 12 weeks. Since it involves healthy people, there…

This early-stage study tests whether IBI3033 is safe and how the body processes it. Eight healthy adults in China will receive either the drug or a placebo. The goal is to check for side effects and measure drug levels in the blood, not to treat any disease.